Status:
COMPLETED
Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens Disease
Lead Sponsor:
Jeppe Lange
Conditions:
Dupuytren Contracture
Eligibility:
All Genders
18+ years
Brief Summary
To evaluate the effect of collagenase clostridium histolyticum treatment at the Department of Orthopaedic surgery at Horsens Regional Hospital after minimum one-year follow-up (FU).
Eligibility Criteria
Inclusion
- dupuytrens disease
- xiapex treatment
Exclusion
- \- demens/other psychiatric diseases
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
199 Patients enrolled
Trial Details
Trial ID
NCT03331926
Start Date
January 1 2017
End Date
December 31 2019
Last Update
April 22 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.